Tonix Pharmaceuticals Holdings shares are trading lower after the company announced receipt of the formal minutes from a recent pre-New Drug Application meeting with the FDA for Tonmya for the management of fibromyalgia.
$TNXP
Biotechnology: Pharmaceutical Preparations
Health Care
Tonix Pharmaceuticals Holdings shares are trading lower after the company announced receipt of the formal minutes from a recent pre-New Drug Application meeting with the FDA for Tonmya for the management of fibromyalgia.